BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 9153487)

  • 1. Muscle fiber atrophy in leg muscles after botulinum toxin type A treatment of cervical dystonia.
    Ansved T; Odergren T; Borg K
    Neurology; 1997 May; 48(5):1440-2. PubMed ID: 9153487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Botulinum toxin type B in the management of dystonia non-responsive to botulinum toxin type A].
    Cardoso F
    Arq Neuropsiquiatr; 2003 Sep; 61(3A):607-10. PubMed ID: 14513166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An open-label study of botulinum toxin A for treatment of tardive dystonia.
    Tarsy D; Kaufman D; Sethi KD; Rivner MH; Molho E; Factor S
    Clin Neuropharmacol; 1997 Feb; 20(1):90-3. PubMed ID: 9037579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muscle structure and stiffness assessment after botulinum toxin type A injection. A systematic review.
    Mathevon L; Michel F; Decavel P; Fernandez B; Parratte B; Calmels P
    Ann Phys Rehabil Med; 2015 Dec; 58(6):343-50. PubMed ID: 26602437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term treatment of cervical dystonia with botulinum toxin A: efficacy, safety, and antibody frequency. German Dystonia Study Group.
    Kessler KR; Skutta M; Benecke R
    J Neurol; 1999 Apr; 246(4):265-74. PubMed ID: 10367694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of focal dystonia with botulinum toxin A].
    Sojer M; Wissel J; Müller J; Poewe W
    Wien Klin Wochenschr; 2001; 113 Suppl 4():6-10. PubMed ID: 15506045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secondary nonresponsiveness to botulinum toxin type A in patients with oromandibular dystonia.
    Adler CH; Factor SA; Brin M; Sethi KD
    Mov Disord; 2002 Jan; 17(1):158-61. PubMed ID: 11835455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remote effects of chronic botulinum toxin treatment: electrophysiologic results Do not indicate subclinical remodelling of noninjected muscles.
    Fertl E; Schnider P; Schneider B; Auff E
    Eur Neurol; 2000; 44(3):139-43. PubMed ID: 11053960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum toxin A in patients with oromandibular dystonia: long-term follow-up.
    Tan EK; Jankovic J
    Neurology; 1999 Dec; 53(9):2102-7. PubMed ID: 10599789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyradiculoneuritis after botulinum toxin therapy for cervical dystonia.
    Burguera JA; Villaroya T; López-Alemany M
    Clin Neuropharmacol; 2000; 23(4):226-8. PubMed ID: 11020130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum Toxin Injections for Leg Contouring in East Asians.
    Cheng J; Chung HJ; Friedland M; Hsu SH
    Dermatol Surg; 2020 Oct; 46 Suppl 1():S62-S70. PubMed ID: 31977500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of inferior lateral pterygoid muscle dystonia with zolpidem tartrate, botulinum toxin injections, and physical self-regulation procedures: a case report.
    Vazquez-Delgado E; Okeson JP
    Cranio; 2004 Oct; 22(4):325-9. PubMed ID: 15532318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Botulinum A toxin treatment in patients with oromandibular dystonia with concomitant malnutrition].
    Budrewicz S; Koszewicz M; Góral M
    Neurol Neurochir Pol; 2003; 37 Suppl 5():55-60. PubMed ID: 15098332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased neck muscle strength is highly associated with pain in cervical dystonia patients treated with botulinum toxin injections.
    Häkkinen A; Ylinen J; Rinta-Keturi M; Talvitie U; Kautiainen H; Rissanen A
    Arch Phys Med Rehabil; 2004 Oct; 85(10):1684-8. PubMed ID: 15468031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muscle paralysis produced by botulinum toxin type A injection in treated torticollis patients compared with toxin naive individuals.
    Sloop RR; Cole D; Patel MC
    Mov Disord; 2001 Jan; 16(1):100-5. PubMed ID: 11215566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose botulinum toxin-a treatment of cervical dystonia - a double-blind, randomized pilot study.
    Laubis-Herrmann U; Fries K; Topka H
    Eur Neurol; 2002; 47(4):214-21. PubMed ID: 12037435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of botulinum toxin type A on vibration induced facilitation of motor evoked potentials in spasmodic torticollis.
    Urban PP; Rolke R
    J Neurol Neurosurg Psychiatry; 2004 Nov; 75(11):1541-6. PubMed ID: 15489383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electromyographic quantification of the paralysing effect of botulinum toxin in the sternocleidomastoid muscle.
    Dressler D; Rothwell JC
    Eur Neurol; 2000; 43(1):13-6. PubMed ID: 10798896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of mirror dystonia as guidance for injection of botulinum toxin in writing dysfunction.
    Singer C; Papapetropoulos S; Vela L
    J Neurol Neurosurg Psychiatry; 2005 Nov; 76(11):1608-9. PubMed ID: 16227568
    [No Abstract]   [Full Text] [Related]  

  • 20. [Initial efficacy of intramuscular injection of botulinum toxin type A against cervical dystonia and general muscular hypertonia in persons with severe motor and intellectual disabilities].
    Adachi M; Saura R
    No To Hattatsu; 2006 Nov; 38(6):425-30. PubMed ID: 17094561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.